Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by John Strang
Prison release is an opportunity for addiction research
Information & Authors Metrics & Citations View Options References Figures Tables Media Share Imprisonment and subsequent release from prison are powerful interventions. They are the social equivalent of major surgery.
Characteristics of deaths due to drug-related causes among individuals recently released from prison in the United Kingdom, 1997–2025
INTRODUCTION There has been an extensive literature describing the substantial elevated risk of drug-related death following an individuals' release from prison after a period of incarceration, a phenomenon often thought to be driven largely by a reduction in opioid tolerance during the period of imprisonment [1-3].
The ‘undone science’ of opioid overdose deaths
The increasing mortality rate from opioid overdose is a major global challenge. High-, middle-, and low-income countries are affected, although the situation in North America is particularly striking. In the USA alone, >100,000 people die from opioid overdose annually, up from <20,000 deaths per annum at the turn of the century, despite a mortality decrease in 2025. Similar disturbing trends are observed in Canada.
Drug use among people in prison: A global review of epidemiology, harms and interventions
INTRODUCTION Drug use, which includes the use of illicit drugs (e.g. cannabis, cocaine, amphetamines and heroin) and extramedical use of prescription drugs (e.g. opioid analgesics and benzodiazepines), is widespread throughout the world. In 2023, an estimated 316 million people, or 6% of the global population aged 15 to 64 years, used drugs in the past year [1]. Drug use occurs along a continuum of severity [2]. For most people, drug use will remain infrequent and transient, with minimal harms.
Non-prescribed ketamine use is rising in the UK
Editorials BMJ 2025; 389 doi: https://doi.org/10.1136/bmj.r1167 Cite this as: BMJ 2025;389:r1167 Irene Guerrini, consultant addiction psychiatrist1 2, Nicola Kalk, consultant addiction psychiatrist1 2, Luke Jelen, clinical lecturer2 3, John Strang, professor1 2 1National Addiction Centre, Institute of Psychiatry Psychology and Neuroscience, King’s College London, London, UK 2South London and Maudsley NHS Foundation Trust, London, UK 3Department of Psychological Medicine, Institute of...
Methods This study was prospectively registered (ISRCTN60538178) and has been reviewed and given favourable opinion by West Midlands – South Birmingham Research Ethics Committee (24/WM/0216). We report this protocol (V1.2, 8.1.25) using the SPIRIT guidelines for reporting of intervention trials (see Supporting Information). Protocol amendments will be agreed and approved by the sponsor and REC. The project is currently in development phase and due to commence recruitment on 1st July 2025.
Patient satisfaction with long-acting injectable buprenorphine: What needs to be measured from the patient’s perspective?
Abstract Background Long-acting injectable buprenorphine is an effective treatment for opioid use disorder. This paper asks: 1. How satisfied are people with long-acting injectable buprenorphine during their first year of treatment? 2. How do people receiving long-acting injectable buprenorphine assess treatment satisfaction/dissatisfaction? 3. Does long-acting injectable buprenorphine require its own specific satisfaction measure?
Eight Tips to Get Your Home Garden Growing
Springtime in Kentucky is a great time to get outside and enjoy the home garden. Every aspiring gardener should do a few things to have a successful season. 1. Plan your garden on paper before you begin. Think about the things you want to grow and when they will be ready to harvest. Draw it out on paper so you can get a visual of what the garden might look like at planting and harvesting times. 2. Select a good gardening site.
Naloxone dosing by non-medical first-responders at opioid overdoses: findings from a qualitative interview study - Harm Reduction Journal
Participants were often uncertain about the types and quantities of drugs consumed by the people whose overdoses they had witnessed. Heroin (either smoked or injected) was presumed to have been taken at every event, often with crack cocaine. In addition, there were occasional reports that people had likely drunk alcohol or used other substances such as spice or benzodiazepines (the co-use of opioids and benzodiazepines is common within the UK but particularly in Scotland) [66].
Employment And Long-Acting Injectable Buprenorphine For Opioid Use Dis
Back to Journals » Substance Abuse and Rehabilitation » Volume 16 Authors Neale J, Cosgrove S, Cassidy J, Strang J Received 7 April 2025 Accepted for publication 16 July 2025 Published 20 August 2025 Volume 2025:16 Pages 211—221 DOI https://doi.org/10.2147/SAR.S528381 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Rajendra Badgaiyan Joanne Neale,1– 3 Sarah Cosgrove,1 James Cassidy,1 John Strang1,3 1Addictions...
Addiction specialists' perspectives on digital contingency management and its role within UK drug and alcohol services: A qualitative exploration
1 INTRODUCTION Contingency management (CM) is a behavioural intervention involving the adjunctive application of positive reinforcement (e.g. monetary incentives) contingent upon evidence of positive behaviour change.
High BMI is a specific risk factor for drug‐related mortality in patients receiving methadone: A case control study
INTRODUCTION People who use heroin are often underweight [1]. Heroin can suppress appetite [1], and users often prioritise drug use over a healthy diet [1]. Heroin use can also increase metabolism and energy expenditure [2] and decrease the absorption of nutrients because of gastrointestinal changes [3]. Malnutrition can also lead to a range of health conditions including a weakened immune system, anaemia and compromised bone physiology [4].
Overdose Detection Among High-Risk Opioid Users Via a Wearable Chest Sensor in a Supervised Injecting Facility: Protocol for an Observational Study
Ethical Considerations Objectives Study Design PneumoWave Biosensor and Data Collection Platform Eligibility Criteria Inclusion Criteria Exclusion Criteria Sample Size Outcome Measures Overview Primary Outcome Measures SIF-Determined Outcome Measures Acceptability Participant Timeline and Study Visits Baseline Procedures Overview Visit 1 Procedures (Performed by Site Research Personnel) Enrollment or baseline Prior to injecting event Acute or overdose eventa Postinjecting event Early...
The multimillion-dollar fight over Washington state’s cap-and-invest program
The multimillion-dollar fight over Washington state’s cap-and-invest program By John Strang Cascade PBS May 3, 2024 Category: Carbon, Climate & Bioenergy Region: United States, US West WASHINGTON — Bolstered by an almost $5 million war chest, supporters of Washington’s cap-and-invest program have begun their efforts to keep the state’s carbon pricing system, which is facing a November recall referendum.
Borderline Personality as a Factor in Late, Missed, and Mis-Diagnosis in Autistic Girls and Women: A Conceptual Analysis
Introduction Autism is diagnosed more frequently among male than female individuals (see end of section for a note on our use of these terms), at rates currently estimated at ∼4:1.1 Among individuals without co-occurring intellectual disability, the sex-based diagnostic ratio widens, with increasing female under-representation at higher ends of the IQ continuum.2 Although some portion of this diagnostic imbalance likely reflects a true differential in underlying prevalence, there is growing...
Cannabis intoxication triggers cognitive mechanism of addiction
Researchers suggest that the main component of cannabis, delta-9-tetrahydrocannabinol (THC), could underpin the cognitive mechanisms behind cannabis use disorder (CUD).
King's innovative AI projects funded to tackle fatal opioid overdoses
Researchers from National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre and King’s College London are part of two collaborative research projects funded by the Office for Life Sciences and the Scottish Government to lessen drug-related deaths across the UK.
HCM technology change management - nice-to-have or necessary?
Ceridian partner Clinton Rubin explains why HCM technology change management is no longer just a nice-to-have and how it can help you get the most out of your new system. John Strang National Sales Executive Clinton Rubin Change management is critical to ensuring the success of organizational change. And yet, some businesses overlook change management when moving to a new human capital management HCM system.
The Intersection of Autism and Transgender and Nonbinary Identities: Community and Academic Dialogue on Research and Advocacy
Address correspondence to: John F. Strang, PsyD, Gender and Autism Program, Center for Neuroscience, Children's National Hospital, 15245 Shady Grove Road Suite 350, Rockville, MD 20850, USA E-mail Address: jstrang@childrensnational.org https://orcid.org/0000-0002-0950-6177 Gender and Autism Program, Center for Neuroscience, Children's National Hospital, Washington, District of Columbia, USA.
Autism in Adulthood
Autism in Adulthood Editor-in-Chief: Christina Nicolaidis, MD, MPH ISSN: 2573-9581 Online ISSN: 2573-959X Published QuarterlyCurrent Volume: 5 Impact Factor: . * *2021 Journal Citation Reports™ (Clarivate, 2022) Autism in Adulthood is the home for research and scholarship on the most pressing issues affecting adults on the autism spectrum, from emerging adulthood to later life.
Prediction of individualised 6-month mortality risk in opioid use disorder
Hostname: page-component-76c49bb84f-229nc Total loading time: 0 Render date: 2025-07-07T13:27:45.645Z Has data issue: false hasContentIssue false Published online by Cambridge University Press: 07 July 2025 Emmert Roberts [Opens in a new window] , Show author details Keywords Mortalityrisk predictionopioid use disorderprognosisepidemiology Information Type Original Article Information The British Journal of Psychiatry , First View , pp.
How do patients feel during the first 72 h after initiating long‐acting injectable buprenorphine? An embodied qualitative analysis
INTRODUCTION New treatments for opioid use disorder have recently been developed, including long-acting buprenorphine implants and injections [1-5]. This paper focuses on long-acting injectable buprenorphine (LAIB).
Cannabis not made safer by increasing its CBD content
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has found no evidence that cannabidiol (CBD) reduces the negative effects of cannabis.
Centering the Inner Experience of Autism: Development of the Self-Assessment of Autistic Traits
Abstract Current tools for identifying autism are critiqued for their lack of specificity and sensitivity, especially in autistic people who are older, have higher verbal ability or significant compensatory skills, and are not cisgender boys. This may reflect the following: the historical focus of autism research on White (cisgender) male, upper and middle class children; limited interest in the inner, lived experience of autism; and the predominance of a deficit-based model of autism.
New collaboration with digital therapeutics company to investigate preventable opioid respiratory deaths
A new collaboration between the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London and the digital therapeutics company, PneumoWave, will undertake a clinical trial collecting data on the features of opioid overdoses within the safety of clinical settings. The research, which is being led by NIHR Maudsley BRC theme lead for Addictions, Professor Sir John Strang, will investigate how to prevent deaths from breathing problems in opioid users.
Take-Home Naloxone and the Prevention of Deaths from Heroin Overdose: Pursuing Strong Science, Fuller Understanding, Greater Impact
Abstract Background and Context: Realization of the life-saving potential of “take-home naloxone” has been a personal journey, but it has also been a collective journey. It has been a story of individual exploration and growth, and also a story of changes at a societal level. “Take-home naloxone” has matured since its first conceptualization a quarter of a century ago.
Maudsley Hospital and King's College London's National Addiction Centre lights up purple to raise awareness for International Overdose Awareness Day
South London and Maudsley NHS Foundation Trust (SLaM), together with together with the National Addiction Centre at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London, are world-leaders in research on prevention of overdose deaths, first proposing Take-Home Naloxone (THN) to reduce heroin overdose death 25 years ago.
Preventing deaths from opioid overdose with Take-Home Naloxone
Over the last 10 years, King’s researchers have developed and adapted an innovative approach which mobilises the general public, including drug users themselves and families as an emergency intervention workforce to prevent overdose from heroin and other opioids. Each year 58 million people use opioids and approximately 120,000 people die around the world from an opioid overdose. To put this in perspective, annual opioid deaths in the UK now exceed deaths from road traffic accidents.
The significant effect of lockdown on gambler's mental health
The 2020 House of Lords report ‘Gambling Harm – Time for Action’ reported that half the adults in the UK gamble at least once a month. A third of a million of UK citizens are “problem” or “disordered” gamblers. The UK COVID-19 lockdown implemented in March 2020 impacted people and society greatly.
Abuse‐deterrent extended‐release oxycodone and risk of opioid‐related harm
Abstract Aim To establish and quantify the association between abuse‐deterrent formulation (ADF) oxycodone and 1‐year risk of opioid‐related harm. Design Propensity score‐matched cohort study of electronic medical records for years 2014–18, with patients followed up for 1 year after their index health‐care visit. Setting More than 70 million patients from 56 US health‐care organizations.
Gender and sexuality in autism, explained
Listen to this story: Gender, like autism, exists on a spectrum. In the 1990s, as growing numbers of children sought care related to their gender identity, clinicians and researchers began to notice a trend: An unexpected number of these children were autistic or had autism traits. The observation has spurred researchers to work to quantify the association.
Consensus Parameter: Research Methodologies to Evaluate Neurodevelopmental Effects of Pubertal Suppression in Transgender Youth
Introduction Standards of care established by the World Professional Association for Transgender Health1 and the Endocrine Society2 recommend pubertal suppression for gender dysphoric transgender youth during early puberty (i.e., Tanner stages 2–3).3,4 Pubertal suppression is achieved through administration of gonadotropin-releasing hormone agonists (GnRHa).
Both sex- and gender-related factors should be considered in autism research and clinical practice
Recently, there has been increasing attention to key intersections between sex, gender and autism (Lai et al., 2015), including the so-called ‘female autism phenotype’ (Mandy et al., 2012), social ‘camouflaging’ (Hull et al., 2017) and experiences of gender diversity in autistic people (van der Miesen et al., 2016). This research and related clinical practice have increased awareness of the breadth of autistic experience.
Global opioid agonist treatment: A review of clinical practices by country
Review Sarah Larney https://orcid.org/0000-0002-5602-4963 NDARC, University of NSW, Sydney, New South Wales, Australia Contribution: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Validation Search for more papers by this author Brandon D. L.
Untreated help seekers in addiction services: an opportunity to reach under-served groups in research
Globally, close to 2 billion people drink alcohol and a quarter of a billion people use illicit drugs. 2 United Nations Office on Drugs and Crime World Drug Report 2017. Global overview of drug demand and supply: latest trends, cross-cutting issues. May, 2017. Although only a minority of substance users go on to develop problems, substance misuse poses an enormous disease burden globally.
Rising opioid-related deaths in England and Scotland must be recognised as a public health crisis
Jo Kimber Jo Kimber Affiliations National Addiction Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London SE5 8BB, UKPopulation Health, Bristol Medical School, UNSW SydneyNational Drug and Alcohol Research Centre, UNSW Sydney Search for articles by this author Matt Hickman John Strang John Strang Affiliations National Addiction Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London SE5 8BB, UK Search for articles by...
Should we worry that take‐home naloxone availability may increase opioid use?
Editorial Should we worry that take‐home naloxone availability may increase opioid use? Basak Tas Corresponding Author E-mail address: basak.tas@kcl.ac.uk https://orcid.org/0000-0002-3137-7631 National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK Search for more papers by this author PDF PDF Share Take‐home naloxone saves lives by preventing deaths from opioid overdose in individual cases.
Long‐term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out‐patients with opioid use disorder
Abstract Aims To assess the long‐term safety of subcutaneous buprenorphine (CAM2038) weekly and monthly depots. Design Phase 3, open‐label, observational, multi‐centre 48‐week trial (ClinicalTrials.gov NCT02672111). Setting Twenty‐six out‐patient sites (United States, United Kingdom, Hungary, Denmark, Sweden, Germany, Australia) between 14 December 2015 and 12 April 2017.
Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations
Harm Reduction Journal201916:25 https://doi.org/10.1186/s12954-019-0296-4 © The Author(s). 2019 Received: 1 January 2019 Accepted: 22 March 2019 Published: 3 April 2019 Abstract Background Options for opioid agonist therapy (OAT) are expanding with the development of prolonged-release (also known as extended-release) 1-week, 1-month, and 6-month formulations of buprenorphine.
Why we need to respect sexual orientation, gender diversity in autism
John Strang Pediatric neuropsychologist, Children’s National Health System Our culture suffers from an ‘eternal child’ bias — the reluctance to acknowledge or see individuals with developmental differences as mature and capable of self-determination. This bias extends to self-determination around sexual orientation and gender identity. In contemporary media, portrayals of autistic people are typically stereotyped and conventional: heterosexual, cisgender and, more often than not, naïve.
Increased Gender Variance in Autism Spectrum Disorders and Attention Deficit Hyperactivity Disorder
Evidence suggests over-representation of autism spectrum disorders (ASDs) and behavioral difficulties among people referred for gender issues, but rates of the wish to be the other gender (gender variance) among different neurodevelopmental disorders are unknown.
Are take‐home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria
The full text of this article hosted at iucr.org is unavailable due to technical difficulties.
Do women with complex alcohol and other drug use histories want women‐only residential treatment?
Women who have complex histories of alcohol and other drug use do not necessarily want or perceive benefit in women‐only residential treatment. Women reported routinely that they had been concerned, anxious or scared about entering women‐only treatment. They attributed these feelings to previous poor relationships with women, being more accustomed to male company and negative experiences of other women‐only residential settings.
Heroin on trial: Systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction
Online ordering is currently unavailable due to technical issues. We apologise for any delays responding to customers while we resolve this.
Counterpoint: Candy Corn Is Great and I'm Gonna Slap the Next Basic Bitch Who Says Otherwise - Slog - The Stranger
Counterpoint: Candy Corn Is Great and I'm Gonna Slap the Next Basic Bitch Who Says Otherwise Rich Smith wrote HyperCritical in this fortnight's print edition of the Stranger—it's a print-edition-only column, so you'll have to pick up the paper to read it—and, needless to say (but I'm saying it anyway), I didn't see Rich's HyperCritical before it went to print and it wouldn't have gone to print if I had seen it and if Rich isn't already cleaning out his desk he should start.
That Time When Jenny Durkan Thought She Could Do Nikkita Oliver Better Than Nikkita Oliver - Slog - The Stranger
That Time When Jenny Durkan Thought She Could Do Nikkita Oliver Better Than Nikkita Oliver This morning, the local comedian Brett Hamill posted on Facebook a video of Jenny Durkan mic-grabbing during her mayoral debate with Cary Moon on Friday in Columbia City. It's just shocking. Durkan reaches over KVRU station manager Sharon Maeda and grabs the mic, and forces her words into it. This incident recalled another one that happened this summer in The Stranger's office.
It Might Become Three Times More Expensive To Visit Mt. Rainier, Olympic National Park - Slog - The Stranger
It Might Become Three Times More Expensive To Visit Mt. Rainier, Olympic National Park It might become three times more expensive to visit Mt. Rainier, Olympic National Park and 15 of the other most visited National Parks around the country.
Initial Clinical Guidelines for Co-Occurring Autism Spectrum Disorder and Gender Dysphoria or Incongruence in Adolescents
Abstract Evidence indicates an overrepresentation of youth with co-occurring autism spectrum disorders (ASD) and gender dysphoria (GD). The clinical assessment and treatment of adolescents with this co-occurrence is often complex, related to the developmental aspects of ASD. There are no guidelines for clinical care when ASD and GD co-occur; however, there are clinicians and researchers experienced in this co-occurrence.
Numbers not good for struggling Florida citrus industry
BARTOW – If this were a numbers game, the Florida citrus industry would have come out a big loser. The amount of citrus grove acreage fell by 4 percent over the past year and the number of trees by 3 percent, both to the lowest levels in 50 years, the U.S. Department of Agriculture reported on Monday. And the value of the 2015-16 citrus crop fell 21 percent in a year, led by a 16 percent decline in production of oranges, grapefruit, tangerines and tangelos, the USDA said.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with John
Contact John, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack